companydata.dkcompanydata.dk

Jorgensen Biotech Consulting ApS: Financial statements 2025

CVR: 42981761

Source: annual report 2025, Danish Business Authority

01/07/2024 – 30/06/2025

Jorgensen Biotech Consulting ApS (CVR 42981761) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,683,534 and a net result of DKK -373,758 compared with DKK 246,920 the year before. That is an increase of 12.4% compared with the year before. Equity in the 2025 report amounted to DKK -134,340. The company had 1 employee in the financial year.

Gross Profit
DKK 2,683,534
Profit/Loss
DKK -373,758
Equity
DKK -134,340
Total Assets
DKK 926,982
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-2.7M-374K-134K1
2024-2.4M247K361K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Jorgensen Biotech Consulting ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About Jorgensen Biotech Consulting ApS

Jorgensen Biotech Consulting ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2022. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Kjærsgaard Jørgensen. The company is owned by JoBiCo Holding ApS. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK 3,669,337 and a net result of DKK 462,628 compared with DKK -373,758 the year before. Equity in the 2026 report amounted to DKK 328,288.

Source: annual report 2026, Danish Business Authority

Other financial years